Renodapt S 360mg Tablet

Renodapt S 360mg tablet is an immunosuppressant containing the active ingredient mycophenolate sodium. It is classified as an inosine monophosphate dehydrogenase (IMPDH) inhibitor. This medicine is used to prevent organ rejection in patients who have received an organ transplant, including kidney, heart, or liver transplantation. It is prescribed as part of combination therapy with other immunosuppressive medications.

This drug is contraindicated in pregnancy due to the risk of birth defects and miscarriage. It should not be used in pregnant women unless no suitable alternatives exist and the potential benefits justify the risks. Female patients of reproductive potential are advised to use effective contraception while taking this tablet to prevent pregnancy.

Live vaccines should not be administered while patients are taking Renodapt S 360mg tablet, as vaccine effectiveness may be reduced and the risk of infection increased. Individuals taking this drug should not donate blood during treatment and for at least six weeks after stopping treatment, to ensure the medication has been adequately cleared from the body before blood donation.

Do not take this medicine if you are allergic to mycophenolate sodium or any other ingredients. Inform your doctor if you have liver or heart disease before beginning treatment. As this drug reduces immune defences, it can increase the risk of skin cancer. Patients must take precautions to limit exposure to sunlight and ultraviolet (UV) light.

Seek immediate medical attention if you develop any bruising under the skin, fever, unexplained tiredness, dizziness, yellowing of the skin or eyes, vision impairment, reduced urine output, or seizures after taking this medicine.

Renodapt S 360mg tablet is an immunosuppressive medication that may affect the infant's developing immune system and should be avoided during breastfeeding.

Prevent organ transplant rejections.

Renodapt S 360mg tablet works by inhibiting the enzyme inosine monophosphate dehydrogenase (IMPDH) and reducing the production of guanosine nucleotides. MMF specifically affects the proliferation of activated T and B lymphocytes. These lymphocytes are key players in the immune response that can lead to the rejection of a transplanted organ.

It is an orally available prescription drug. Your physician will decide the dose and duration of the treatment based on your disease condition, severity, and other factors. Always take Renodapt S 360mg tablet as prescribed by your doctor. Do not open, crush, break, or chew the medicine. Take the medicine at the same time every day as advised by your doctor.

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Serious Infections, fever, or sore throat Unusual bleeding or bruising Low blood cell count Severe allergic reactions Common Higher risk of developing lymphoma and other cancers Nausea, abdominal pain Diarrhea Constipation Loss of appetite Shortness of breath Weight loss Increased heartbeat Headache Blood pressure problem Anaemia

It is necessary to take the prescribed dose exactly as instructed by your doctor. Inform your doctor about all the medications (prescription, over-the-counter, and herbal) you are taking, as they can interact with this drug. If you plan to conceive or suspect you might be pregnant while taking Renodapt S 360mg tablet, it is important to consult your doctor immediately. They may suggest switching to alternative medications that are safer during pregnancy or adjusting your treatment plan.